Management of QT prolongation induced by anti-cancer drugs: Target therapy and old agents. Different algorithms for different drugs
Carmela Coppola, Nicola Maurea(Cancer Institute (WIA)), Claudio Arra(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Anna Di Rienzo(University of Chicago), Giovanna Piscopo(University of Cagliari), Antônio Barbieri
Cited by 80
Related Papers
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin
|Cardiovascular Diabetology|2021|368
Getting genetic ancestry right for science and society
|Science|2022|226
Trastuzumab Adjuvant Chemotherapy and Cardiotoxicity in Real-World Women With Breast Cancer
|Journal of Cardiac Failure|2011|116
Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experience
|Cancer Biology & Therapy|2010|108
Resveratrol in Cancer Patients: From Bench to Bedside
|International Journal of Molecular Sciences|2020|105